medigraphic.com
SPANISH

Revista de Hematología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

<< Back Next >>

Rev Hematol Mex 2018; 19 (2)

Disorders of iron metabolism: Too little, too much, too late

Kahn MJ
Full text How to cite this article

Language: English
References: 11
Page: 73-76
PDF size: 273.85 Kb.


Key words:

Iron, Hepcidin, Iron deficiency, Iron overload, Hemochromatosis.

ABSTRACT

Elemental iron is essential for life and the biochemistry and physiology of iron balance and metabolism are now understood at the molecular level. Although iron deficiency remains a worldwide problem due to nutritional inadequacy, malabsorption, and blood loss, iron is often easily replaced. On the opposite end of the spectrum, mutations in genes responsible for normal iron hemostasis can result in hereditary hemochromatosis, a disease of iron overload. In this paper, the molecular biology of iron will be discussed in the context of human disease.


REFERENCES

  1. Sotelo A, González-Osnaya L, Sánchez-Chinchillas A, Trejo A. Role of oxalate, phytate, tannins and cooking on iron bioavailability from foods commonly consumed in Mexico. Int J Food Sci Nutr 2010;61:29-39.

  2. Reichert CO, da Cunha J, Levy D, Maselli LMF, Bydlowski SP, Spada C. Hepcidin: Homeostasis and diseases related to iron metabolism. Acta Haematol 2017;137:220-236.

  3. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011;434:365-81.

  4. Moretti D, Goede JS, Zeder, et al. Oral iron supplements increase hepcidin and decrease iron absorption form daily or twice-daily dose in iron depleted young women. Blood 2015;126:1981-9.

  5. Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice daily split dosing in iron-depleted women: two open-lable, randomised controlled trials. Lancet Haematol 2017;11:e524-e533.

  6. Christenson WN, Grace WJ, Henley ED, Wolff HG. Absorption of iron from the gastrointestinal tract; a comparative study of the oral iron tolerance test in human beings using stable and radioactive iron. Am J Clin Nutr 1956;4:609-18.

  7. Eliadoue E, Kini G, Huang J, Champion A, Inns SJ. Intravenous iron replacement improves quality of life in hypoferritinemic inflammatory bowel disease patients with and without anemia. Dig Dis 2017;35:444-448.

  8. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 1999;69:S61-6.

  9. Poggiali E, Andreozzi F, Nava I, Consonni D, Graziadei G, Cappellini MD. The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment. Am J Hematol 2015;90:306-9.

  10. Gerhard GS, Paynton BV, DiStefano JK. Identification of genes for hereditary hemochromatosis. Methods Mol BiolA 2018;1706:353-365.

  11. Casu C, Nemeth R, Rivella S. Hepcidin agonists as therapeutic tools. Blood 2018;Mar 9 [epub ahead of print].




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hematol Mex. 2018;19